Reach Us +44-1647-403003
Editor - Hiranmoy Das | The Ohio State University | 9653
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Relevant Topics

Hiranmoy Das

Hiranmoy Das
Hiranmoy Das, PhD
Associate Professor & Director
Cardiovascular Stem Cell Research Laboratories
The Ohio State University
Tel. (614) 688-8711
Fax (614) 293-5614
The Ohio State University


Hiranmoy Das is an Associate Professor of Medicine & Director of Cardiovascular Stem Cell Research Laboratories, The Ohio State University, Columbus, USA.

Research Interest

Stem cell therapy using autologous stem cells to treat degenerative diseases is promising; however, the limited availability and compromised quality of progenitor cells in aged and diseased patients limit its therapeutic potential. Alternatively, use of cord blood-derived stem cells is advantageous as it is easy to harvest, harmless to donor, ethical, ontogenetically primitive and can be stored in cord blood bank for years.

Current investigation focuses on the role of KLF2 in the genetically altered murine model in the context of rheumatoid arthritis.



Global Speakers in the subject

Global Experts in the subject